Eu Ivdd Eu Ivd Annex 2 List B No Longer On The Market 🇹🇼 Taiwan

MultiSure GCTU

Apex Biotechnology Corp. · 🇹🇼 Taiwan
Devices (same UDI-DI)
1
Certificates
1
Countries
0
Notified Bodies
1

Basic Information

Primary DI
D-47136487613A062
Basic UDI-DI Code
B-47136487613A062
Reference
S81001, S81002
Device Types
Single use
Regulation
Eu Ivdd
Classification
Eu Ivd Annex 2 List B
Status
No Longer On The Market

Additional Description

The MultiSure GCTU Monitoring System is intended for quantitative measurement of glucose, cholesterol, triglyceride and uric acid level in fresh capillary whole blood. Testing is done outside the body (in vitro diagnostic use). It is indicated for self-testing by individuals at home or for clinical settings by healthcare professional, as an aid in monitoring blood glucose, cholesterol, triglyceride and uric acid level. The MultiSure GCTU system is not intended for diagnosis or screening of diabetes, or for neonatal use.

CND Nomenclature Codes

Code Description
W010106010801 BLOOD TEST STRIPS CONTROLS
W0101060199 BLOOD TEST STRIPS (CC) - RAPID TESTS AND "POINT OF CARE" - OTHER
W0101060105 TRIGLYCERIDE TEST STRIPS
W0101060102 CHOLESTEROL TEST STRIPS
W0101060101 GLUCOSE TEST STRIPS
W020106019099 VARIOUS DIABETES MONITORING INSTRUMENTS - OTHER

Certificates

Type Number
IVDD Annex IV (excluding sections 4, 6) HL 2100077-1

Similar Devices

Other on-the-market devices with the same classification (Eu Ivd Annex 2 List B) and regulation (EU IVDD).

View all